Company Profile

Akermin Incorporated
Profile last edited on: 3/8/2019      CAGE: 3ZDJ9      UEI: TN4RE3JDP2K9

Business Identifier: Biocatalysis and nanotechnology
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1005 North Warson Road Suite 101
St. Louis, MO 63132
   (314) 669-2599
Location: Single
Congr. District: 01
County: St. Louis

Public Profile

After Akermin decided to cease operations in the Fall 2016, Canadian carbon capture and storage technology innovator CO2 Solutions Inc. - a rival to Akermin in the field of enzyme-based carbon capture - agreed to purchase several assets of former US-based competitor. Akermin, Inc. had been a cleantech technology development company developing and commercializing a polymer technology originally developed as St Louis University. Based on enzyme stabilization and operation to lower costs and create efficiencies in carbon capture systems, biofuel cells, natural gas sweetening, hydrogen production, landfills, and cement kilns, the process involves use of an enzyme, carbonic anhydrase, to accelerate absorption of carbon dioxide. The firm's core technology had been a proprietary enzyme delivery system that integrates the enzyme in a polymer allowing it to effectively work as a catalyst over extended periods in harsh industrial environments. Initial targeted markets are the CO2 separation industries of natural gas processing, fertilizer production, gasification and industrial hydrogen production. Akermin is currently transitioning from laboratory research to field demonstrations and establishing industrial partnerships for commercial delivery. Initial commercial sales are expected in 2015 targeting multi-billion dollar industrial carbon capture applications including natural gas, fertilizer, gasification, industrial hydrogen, oil sands, and power plants. Development for the use of stabilized enzymes in the food processing, biofuels, chemical, and pharmaceutical industries is also under way.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 2 AF $849,880
Project Title: Hierarchically-Structured Bio-Electrocatalyst Materials Design
2010 1 NSF $146,837
Project Title: Stabilized Bioanode Enzymes for Micro Power Biofuel Cells

Key People / Management

  Barry Blackwell -- President and CEO

  Bob Martinelli -- Director, Engineering Operations

  John Reardon -- Director, Engineering

  Donna Schnieders -- Director of Finance

  Alex Zaks -- Chief Technology Officer; Vice President, Research